Processa Pharmaceuticals, Inc. - 8-K Filing
Processa Pharmaceuticals acquires Vidya Therapeutics in a stock-and-preferred-stock merger deal with $200M private placement financing (Items: 5.03 of this Current Report on Form 8-K, which is incorporated into this Item 1, 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2, 7.01 of this Current Report on Form 8-K, including the information in the press release attached as Exhibit 99)
Tickers: $PCSA